ArticleCancer cell international2021

Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.

Xianbin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.